A low plasma level of PP has been reported in patients with pancreatic ductal adenocarcinoma [211], whereas an elevated plasma PP level was reported in patients with an endocrine pancreatic tumor [212]. The gene discussed is PPY; the disease is pancreatic neuroendocrine tumor.